Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 133 to 134 of 134 entries
Sorted by: Best Match Show Resources per page
Leveraging Immunopeptidomics To Study and Combat Infectious Disease.

mSystems

Leddy OK, White FM, Bryson BD.
PMID: 34342538
mSystems. 2021 Aug 31;6(4):e0031021. doi: 10.1128/mSystems.00310-21. Epub 2021 Aug 03.

T cells must recognize pathogen-derived peptides bound to major histocompatibility complexes (MHCs) in order to initiate a cell-mediated immune response against an infection, or to support the development of high-affinity antibody responses. Identifying antigens presented on MHCs by infected...

Cite
Leddy OK, White FM, Bryson BD. Leveraging Immunopeptidomics To Study and Combat Infectious Disease. mSystems. 2021;6(4):e0031021doi: 10.1128/mSystems.00310-21.
Leddy, O. K., White, F. M., & Bryson, B. D. (2021). Leveraging Immunopeptidomics To Study and Combat Infectious Disease. mSystems, 6(4), e0031021. https://doi.org/10.1128/mSystems.00310-21
Leddy, Owen K, et al. "Leveraging Immunopeptidomics To Study and Combat Infectious Disease." mSystems vol. 6,4 (2021): e0031021. doi: https://doi.org/10.1128/mSystems.00310-21
Leddy OK, White FM, Bryson BD. Leveraging Immunopeptidomics To Study and Combat Infectious Disease. mSystems. 2021 Aug 31;6(4):e0031021. doi: 10.1128/mSystems.00310-21. Epub 2021 Aug 03. PMID: 34342538; PMCID: PMC8407116.
Copy Download .nbib Format: NLM
Findings among Indigenous participants of the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019.

Canada communicable disease report = Releve des maladies transmissibles au Canada

Tarasuk J, Sullivan M, Bush D, Hui C, Morris M, Starlight T, Cholette F, Jonah L, Bryson M, Paquette D, Masching R.
PMID: 33679247
Can Commun Dis Rep. 2021 Jan 29;47(1):37-46. doi: 10.14745/ccdr.v47i01a07. eCollection 2021 Jan 29.

BACKGROUND: The Tracks survey of people who inject drugs (PWID) collected data in 14 sentinel sites across Canada (2017-2019). These findings describe the prevalence of human immunodeficiency virus (HIV), hepatitis C and associated risk behaviours among Indigenous participants.METHODS: Information...

Cite
Tarasuk J, Sullivan M, Bush D, et al. Findings among Indigenous participants of the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019. Can Commun Dis Rep. 2021;47(1):37-46doi: 10.14745/ccdr.v47i01a07.
Tarasuk, J., Sullivan, M., Bush, D., Hui, C., Morris, M., Starlight, T., Cholette, F., Jonah, L., Bryson, M., Paquette, D., & Masching, R. (2021). Findings among Indigenous participants of the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019. Canada communicable disease report = Releve des maladies transmissibles au Canada, 47(1), 37-46. https://doi.org/10.14745/ccdr.v47i01a07
Tarasuk, Jill, et al. "Findings among Indigenous participants of the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019." Canada communicable disease report = Releve des maladies transmissibles au Canada vol. 47,1 (2021): 37-46. doi: https://doi.org/10.14745/ccdr.v47i01a07
Tarasuk J, Sullivan M, Bush D, Hui C, Morris M, Starlight T, Cholette F, Jonah L, Bryson M, Paquette D, Masching R. Findings among Indigenous participants of the Tracks survey of people who inject drugs in Canada, Phase 4, 2017-2019. Can Commun Dis Rep. 2021 Jan 29;47(1):37-46. doi: 10.14745/ccdr.v47i01a07. eCollection 2021 Jan 29. PMID: 33679247; PMCID: PMC7919774.
Copy Download .nbib Format: NLM
Showing 133 to 134 of 134 entries